Pharmaceutical Executive
CMS Signals Looming Sunshine Act Audits: How to Prepare
March 1, 2024
New guidance suggests that CMS may be ramping up Sunshine Act auditing activities, potentially resulting in monetary liability for noncompliant reporting entities.
After more than a decade of relative inactivity, the Centers for Medicare & Medicaid Services(CMS) has signaled that it may soon commence audits of reporting entities under the Sunshine Act.
Published by Pharmaceutical Executive on March 1, 2024, available at https://www.pharmexec.com/view/cms-signals-looming-sunshine-act-audits-how-to-prepare.
Contacts
Capabilities
Suggested News & Insights
Fifth Circuit Panel Produces Three Opinions Wrestling with Application of First to File BarMarch 13, 2026Sidley Wins a Trio of Awards at the 2026 Benchmark Litigation US AwardsMarch 12, 2026Sidley Advises Verdane in Its Partnership With SmartboxMarch 12, 2026New U.S. DOJ Antitrust Leadership Signals More Criminal Prosecutions and Longer Prison SentencesMarch 6, 2026Strictly Enforcing Rule 9(b), Second Circuit Affirms Dismissal of FCA Claim Based on Allegedly Defective Medical DevicesMarch 4, 2026Court Grants Motion to Dismiss FCA Claim for Failure Adequately to Plead ScienterMarch 3, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory

